The House Judiciary Committee on Nov. 20 voted 24-10 to advance
the Marijuana Opportunity Reinvestment and Expungement Act, or the
"MORE" Act (the Act). As referenced in a recent Law360 article, the overarching goal of
the Act is to decriminalize and normalize cannabis. The Act would
provide relief to two main groups of individuals: (1) cannabis
business owners; and (2) individuals with cannabis convictions. Our
focus is on the Act's potential benefits for and effect on
current and future cannabis business owners.
The Act's removal of cannabis containing THC from the
controlled substances list would alleviate numerous barriers for
cannabis businesses. One of these obstacles is the dreaded section
280E of the Internal Revenue Code, which prohibits business
deductions for businesses “trafficking” in substances
listed on either Schedule I or II of the Controlled Substances Act.
Cannabis is currently listed as a Schedule I controlled substance.
Because of this,